ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.491,91
0,29%
S&P 500
5.187,70
0,13%
Dow Jones
38.884,26
0,00%
Euro vs US Dollar
1,07455
-0,04%
Bitcoin
62.272,58
-0,10%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. AMEX
  6. Heat Biologics Inc (HTBX)

  7. Heat Biologics Inc (HTBX) News

HTBX

Heat Biologics (HTBX)

Heat Biologics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:HTBX
DatumZeitQuelleÜberschriftSymbolFirma
15/05/202322h34Edgar (US Regulatory)Quarterly Report (10-q)AMEX:HTBXHeat Biologics Inc
15/05/202322h28Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
31/03/202322h15Edgar (US Regulatory)Annual Report (10-k)AMEX:HTBXHeat Biologics Inc
31/03/202322h09Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
23/03/202321h06Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
13/03/202312h54Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
02/02/202322h06Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
30/12/202222h06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:HTBXHeat Biologics Inc
09/12/202223h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:HTBXHeat Biologics Inc
09/12/202223h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:HTBXHeat Biologics Inc
09/12/202222h59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:HTBXHeat Biologics Inc
14/11/202222h54Edgar (US Regulatory)Quarterly Report (10-q)AMEX:HTBXHeat Biologics Inc
14/11/202222h46Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
16/09/202222h36Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
22/08/202213h31Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
10/08/202222h12Edgar (US Regulatory)Quarterly Report (10-q)AMEX:HTBXHeat Biologics Inc
10/08/202222h07Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
06/06/202222h29Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:HTBXHeat Biologics Inc
16/05/202223h25Edgar (US Regulatory)Quarterly Report (10-q)AMEX:HTBXHeat Biologics Inc
16/05/202222h44GlobeNewswire Inc.NightHawk Biosciences Provides First Quarter 2022 Business UpdateAMEX:HTBXHeat Biologics Inc
10/05/202214h00GlobeNewswire Inc.NightHawk Biosciences to Present at the 4th Annual Treg Directed Therapies Summit on PTX-35AMEX:HTBXHeat Biologics Inc
03/05/202213h15Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
03/05/202213h00GlobeNewswire Inc.Heat Biologics Completes Name Change to NightHawk Biosciences; Trading to Commence Under “NHWK” Effective at the Market Open TodayAMEX:HTBXHeat Biologics Inc
27/04/202214h00GlobeNewswire Inc.Heat Biologics (NightHawk Biosciences) Announces that its Elusys Therapeutics Subsidiary has Executed a Contract to Deliver ANTHIM® to the Canadian GovernmentAMEX:HTBXHeat Biologics Inc
20/04/202214h08Edgar (US Regulatory)Current Report Filing (8-k)AMEX:HTBXHeat Biologics Inc
20/04/202214h00GlobeNewswire Inc.Heat Biologics (“NightHawk Biosciences”) Completes Acquisition of Elusys TherapeuticsAMEX:HTBXHeat Biologics Inc
19/04/202217h00GlobeNewswire Inc.Heat Biologics Announces Planned Name Change to NightHawk Biosciences, Reflecting Company’s Evolution, Therapeutic Pipeline Expansion, Vertical Integration and New Biodefense CapabilitiesAMEX:HTBXHeat Biologics Inc
18/04/202222h00GlobeNewswire Inc.REMINDER: Heat Biologics to Host Planned Investor and Media Livestream Event on Tuesday, April 19th at 10:30 AM ET to Discuss Latest DevelopmentsAMEX:HTBXHeat Biologics Inc
18/04/202214h30GlobeNewswire Inc.Heat Biologics’ Scorpion Subsidiary Announces Planned Development of New Kansas Commercial/Biodefense Biomanufacturing FacilityAMEX:HTBXHeat Biologics Inc
14/04/202218h35GlobeNewswire Inc.Heat Biologics’ Announces Planned Investor and Media Livestream Event to Discuss Latest DevelopmentsAMEX:HTBXHeat Biologics Inc
 Showing the most relevant articles for your search:AMEX:HTBX

Kürzlich von Ihnen besucht

TG
BAYN
Bayer
NYSE
MRK
Merck
NASDAQ
NVDA
NVIDIA
NYSE
NKE
Nike
NASDAQ
TSLA
Tesla
NASDAQ
MSFT
Microsoft
FX
EURGBP
Euro vs Sterling
AMEX
XLE
Energy Select Sector SPDR
TG
LHA
Deutsche Lufthansa
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
AMZN
Amazon.com
TG
MBG
MercedesBenz
AMEX
XLF
Financial Select Sector
DBI
DAX
DAX
DBI
MDAX
MDAX
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten